Please login to the form below

Not currently logged in
Email:
Password:

tocilizumab

This page shows the latest tocilizumab news and features for those working in and with pharma, biotech and healthcare.

Roche's Actemra/RoActemra receives new European approval

Roche's Actemra/RoActemra receives new European approval

Roche is celebrating two new approvals in the EU, including Actemra/RoActemra (tocilizumab), which becomes the first therapy approved in Europe to treat giant cell arthritis (GCA).

Latest news

More from news
Approximately 7 fully matching, plus 46 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics